why choose us

Clinical Trials Search

Showing 17,840 of 132,963 result(s)
Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

Status: Completed

Condition: Alzheimer Disease

Interventions: Participants will use the GENUS light and sound device at home for 60 minutes daily for 12 months

Date: 2022-11-29

Effect of Knee Pain on Walking Biomechanics

Status: Completed

Condition: Osteoarthritis, Knee

Interventions: 10 mL of 1% lidocaine hydrochloride for each intraarticular knee injection

Date: 2022-11-29

Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

Status: Completed

Condition: NSCLC

Interventions: MYTX-011 will be administered as an intravenous infusion every 21 days for up to two years.

Date: 2022-11-29

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Status: Completed

Condition: Acute Gout Flare

Interventions: An initial loading dose of 2000 mg dapansutrile on Day 1 followed by a maintenance regimen of 1000 mg dapansutrile twice daily starting 12 hours later

Date: 2022-11-29

Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention

Status: Completed

Condition: COPD Exacerbation Acute

Interventions: Subcutaneous Immunoglobin Replacement Therapy, SCigR

Date: 2022-11-29

Non-invasive Pulmonary Artery Prediction (ADOPTS)

Status: NOT_YET_RECRUITING

Condition: Heart Failure

Interventions: Connect to a heart monitor to record heart rate, blood pressure and blood oxygen levels Place sterile sheets on chest and neck (or groin area) Clean t

Date: 2022-11-29

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

Status: Completed

Condition: Educational Intervention

Interventions: The intervention will occur at a separate dedicated in-person visit with the patient navigator estimated to last 30-45 minutes.
The Pre-Intervent

Date: 2022-11-29

Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma

Status: Completed

Condition: Diffuse Large B Cell Lymphoma

Interventions: Epcoritamab will be administered by subcutaneous (SC) injections in 28-day cycles for up to 12 cycles.

Date: 2022-11-29

A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype

Status: COMPLETED

Condition: Alpha-1 Antitrypsin Deficiency

Interventions: Tablets for oral administration.

Date: 2022-11-29

Repeatability and Reproducibility of Lens Zonule Length Measurement Using ArcScan Insight 100

Status: Active, not recruiting

Condition: Zonule of Zinn Abnormality
Zonular Cataract

Interventions: Device: ArcScan Insight 100 very high-frequency digital ultrasound
The Insight-100 (ArcScan Inc., Golden, CO, USA) employs the high-frequency B-s

Date: 2022-11-29